EC 221-800-8
Also known as FDCA.
chemXplore tracks 5 projects producing 2,5-furandicarboxylic acid, of which 2 are active.
Of the active ones, 2 new construction.
The arrangement is intended to give prospective plant licensees greater demand visibility and support investment decisions.
Independent startup to commercialize plant‑based high‑performance polyesters (PISOX, PISA, PEIT/PEIF) using common monomers and existing industrial assets.
H1: revenues €4.7m, EBITDA -€18.8m, cash €23.9m; first FDCA batch produced; planned equity raise ≥€55m and proposed €20m facility; Worley contractual close‑out finalised.
First FDCA batch produced at Delfzijl; product qualification begins with aim for commercial sales by end of 2026.
Capacity reservation secures prospective access to plant-based PEF (releaf®) for thermoformed trays and high-barrier packaging while technical and regulatory evaluations continue.
Purification unit brought online, completing commissioning of all major process units; integrated start-up moves toward first FDCA production and end‑2026 commercial deliveries.
Oxidation unit commissioned; full start-up and first FDCA production targeted end‑2026; 22 offtakes and >150 kt reservations secured; pursuing €55m equity plus a €20m NOM loan.
Trial explores plant-based PEF in small-format bottles for functional beverage shots, assessing processing, barrier performance and shelf-life across the production chain.
Parliament event on 24 June 2026 will examine whether bio‑based and circular carbon can underpin European chemical competitiveness and cut fossil feedstock reliance.
Sale transfers Ray Technology patents for bio-based MEG/MPG (up to end‑2023). Seller refocuses on FDCA/PEF; €2.7M proceeds used to repay debt (€2.0M) and dismantle pilot (€0.7M).
chemXplore tracks 4 plants producing 2,5-furandicarboxylic acid in 3 countries.
plants
plants
A subscription lists every plant we track for 2,5-furandicarboxylic acid, with its owners and capacity. What a subscription does